Study investigates molecular biomarkers' association with prognosis and brain volume in relapsing-remitting multiple sclerosis patients, suggesting potential predictive value.
This study aimed to investigate the relationship between baseline biomarker levels(Neurofilament Light Chain(NfL); Brain-Derived Neurotrophic Factor(BDNF); Runt-Related Transcription Factor 1(RUNX1);and Neurogranin(NRGN))measured at the time of diagnosis and disease activity,prognosis,and brain volume measurements at follow-up in patients with relapsing-remitting multiple sclerosis(RRMS).
No takes yet. Share an insight, caveat, or question.
Ersöz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: